Add BrightSurf on Google Email

Strokes may be associated with cocaine and amphetamine abuse

A study published in Archives of General Psychiatry found a significant association between cocaine and amphetamine abuse and an increased risk of stroke. The use of these stimulant drugs may raise blood pressure and contribute to narrowing blood vessels, leading to an increased risk of hemorrhagic and ischemic strokes.

SourceJAMA Network·JournalArchives of General Psychiatry·DateApr 2, 2007

Recent study confirms warning signs of painkiller abuse

A recent study by Robert J. Gatchel confirmed that patients scoring high on the Pain Medication Questionnaire (PMQ) test demonstrate higher levels of substance abuse, psychopathology, and physical/life functioning problems. The study found that patients in the high-PMQ group are 3.2 times more likely to request early medication refills.

SourceBlackwell Publishing Ltd.·JournalPain Practice·DateSep 6, 2006

Study elicits 'child's eye' view of methamphetamine abuse and its effects

A study investigates how methamphetamine use affects children's psychological development and behavior, revealing that despite traumatic experiences, many focus on losing their parents rather than the drug itself. The researchers developed materials for foster parents and child-welfare workers to help these children recover.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalChildren and Youth Services Review·DateJun 12, 2006

Study results offer guidance in treatment

The largest clinical trial on pharmacologic and behavioral treatments for alcohol dependence shows that medication treatment significantly improves outcomes compared to placebo. The study also provides new safety data on prescription drugs naltrexone and acamprosate, suggesting a high degree of comfort for prescribing physicians.

SourceScripps Research Institute·JournalJAMA·DateMay 2, 2006

Racial disparities in access to medicines increase after implementation of prescription surveillance

A study found that prescription monitoring programs can reduce problematic use of benzodiazepines but also decrease access to appropriate treatment for patients with chronic illnesses. Racial disparities in access to effective care were exacerbated by these policies, highlighting the need for re-examining health policy impacts.

SourceHarvard Medical School·JournalArchives of Internal Medicine·DateMar 13, 2006